Traders Sell CVS Health (CVS) on Strength (CVS)

Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading hours on Thursday. $195.45 million flowed into the stock on the tick-up and $242.70 million flowed out of the stock on the tick-down, for a money net flow of $47.25 million out of the stock. Of all stocks tracked, CVS Health had the 24th highest net out-flow for the day. CVS Health traded up $1.93 for the day and closed at $75.13

A number of analysts recently commented on CVS shares. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health in a research report on Sunday, September 10th. Oppenheimer reiterated a “buy” rating and set a $95.00 price objective on shares of CVS Health in a research report on Monday, October 9th. Leerink Swann reiterated an “outperform” rating and set a $85.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Tuesday, November 7th. SunTrust Banks set a $85.00 price target on CVS Health and gave the company a “buy” rating in a report on Thursday, October 12th. Finally, Citigroup set a $76.00 price target on CVS Health and gave the company a “hold” rating in a report on Monday, December 4th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $86.68.

The firm has a market cap of $76,110.00, a P/E ratio of 15.52, a price-to-earnings-growth ratio of 1.29 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.64 EPS. research analysts expect that CVS Health Corp will post 5.9 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s dividend payout ratio is currently 41.32%.

In other news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the transaction, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.61% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CVS. Private Advisor Group LLC lifted its position in CVS Health by 231.6% during the 1st quarter. Private Advisor Group LLC now owns 132,340 shares of the pharmacy operator’s stock worth $7,388,000 after acquiring an additional 92,431 shares in the last quarter. Roof Eidam & Maycock ADV acquired a new position in CVS Health during the 1st quarter worth approximately $1,649,000. Pinnacle Associates Ltd. lifted its position in CVS Health by 12.7% during the 1st quarter. Pinnacle Associates Ltd. now owns 227,377 shares of the pharmacy operator’s stock worth $17,849,000 after acquiring an additional 25,687 shares in the last quarter. Brandes Investment Partners LP acquired a new position in CVS Health during the 1st quarter worth approximately $7,401,000. Finally, Hayek Kallen Investment Management lifted its position in CVS Health by 6.5% during the 1st quarter. Hayek Kallen Investment Management now owns 14,425 shares of the pharmacy operator’s stock worth $1,132,000 after acquiring an additional 882 shares in the last quarter. 81.63% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Traders Sell CVS Health (CVS) on Strength (CVS)” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/3126109/traders-sell-cvs-health-cvs-on-strength-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2018 Ticker Report. Google+.